---
title: Pharmaceutics International, Inc. vs Bend Bioscience
slug_a: pharm-int
slug_b: societalcdmo
site: cdmo
review_signal_gate: closed
canonical_path: /compare/pharm-int/societalcdmo
generated_by: BioBM Editorial AI
---

# Pharmaceutics International, Inc. vs Bend Bioscience

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Pharmaceutics International, Inc. (pharm-int) is listed for cdmo. Drug product CDMO specializing in aseptic injectables, oral solid dose, lyophilization, and prefilled syringes with 30+ years of experience in complex formulations and potent compounds; now part of Jabil.

Services: 15. Modalities: 1. Indications: 0. Locations: 8. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (15).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Bend Bioscience (societalcdmo) is listed for cdmo. U.S. pharmaceutical CDMO offering design, development, and manufacturing from early formulation to commercial-scale production, with cGMP capabilities including spray drying, particle engineering, and complex oral dosage forms.

Services: 12. Modalities: 1. Indications: 0. Locations: 9. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (12).

Review summary: Review summary withheld until site-level review gate opens.